Company data
Summit Therapeutics Inc. employees and revenue per employee
SMMT · Biotechnology · $13.4B market cap
Summit Therapeutics Inc. had 76 employees at the end of fiscal Dec 2022, down 27.6% from a year earlier. Revenue for the year was $583,190, down 56.4% from a year earlier, or $8K per employee. Revenue fell, and headcount fell or held flat with it.
The latest annual report we hold is more than two years old, so these numbers may be out of date.
Employees
76
-27.6% YoY
Revenue
$583,190
-56.4% YoY
Revenue / employee
$8K
Peer median $574K
Rank in industry
40 of 40
Biotechnology
Open roles
72
947 per 1,000 staff
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Hover a year for the numbers.
| Year ending | Employees | Revenue | Per employee | Staff YoY | Revenue YoY |
|---|---|---|---|---|---|
| Dec 2022 | 76 | $583,190 | $8K | -27.6% | -56.4% |
| Dec 2021 | 105 | $1.3M | $13K | +32.9% | +112.7% |
| Dec 2020 | 79 | $628,875 | $8K | — | — |
Open roles on its job board: 72 (947 per 1,000 staff, against its latest annual headcount), as of 2026-10-07. Tracked since 2026-10-03. No 90 day change yet.
Summit Therapeutics Inc. against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| PTGX Protagonist Therapeutics, Inc. | 132 | $46.0M | $349K | Hiring into decline |
| NUVB Nuvation Bio Inc. | 298 | $62.9M | $211K | Efficient growth |
| KYMR Kymera Therapeutics, Inc. | 238 | $39.2M | $165K | Hiring into decline |
| RLAY Relay Therapeutics, Inc. | 192 | $15.4M | $80K | Leaner |
| PRAX Praxis Precision Medicines, Inc. | 116 | $8.6M | $74K | Efficient growth |
| PGEN Precigen, Inc. | 160 | $9.7M | $61K | Efficient growth |
| IMNM Immunome, Inc. | 177 | $6.9M | $39K | Hiring into decline |
| CRNX Crinetics Pharmaceuticals, Inc. | 594 | $7.7M | $13K | Efficient growth |
| SMMT Summit Therapeutics Inc. | 76 | $583,190 | $8K | Contracting |
Questions about Summit Therapeutics Inc.
- How many employees does Summit Therapeutics Inc. have?
- Summit Therapeutics Inc. reported 76 employees for the fiscal year ending Dec 2022, in the annual report it filed on March 9, 2023. That is down 27.6% from a year earlier.
- What is Summit Therapeutics Inc.'s revenue per employee?
- Summit Therapeutics Inc. brought in $583,190 of revenue in fiscal Dec 2022, which is $8K per employee. That ranks 40 of 40 companies we track in Biotechnology, where the median is $574K.
- Is Summit Therapeutics Inc. hiring?
- Summit Therapeutics Inc.'s public job board listed 72 open roles on October 7, 2026, about 947 per 1,000 staff.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare SMMT with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in Summit Therapeutics Inc.'s annual reports (Form 10-K), latest filed March 9, 2023. This is data, not a recommendation to buy or sell SMMT.